New Era Alliance

Specialty Biopharmaceutical product consulting firm focused on providing unique and actionable strategic and tactical Market Access (Payer, Patient, Trade / Channel and Provider) insights during the commercialization planning and execution stage as well as at each stage of a Brand's life cycle. •Conducts Primary and Secondary payer / reimbursement market research for Specialty Products in multiple therapeutic areas. •Develops channel, payer and patient / provider access strategies: Trade / Channel, Specialty, Retail Pharmacies, Oncology Distributors, Oncology GPOs and acute care GOPs. •Develops commercialization plans including pricing, contracting, payer strategies and channel strategies for Specialty Products. •Trains National Account Managers and Directors on how to build and maintain best-in-class business to business relationships in the Specialty Product segment – Specialty Pharmacies, IDN Specialty Pharmacies, Specialty Distributors and other specialty channel partners. •Leads the RPI / RFP search, selection and implementation of business arrangements with Patient Hub Providers, Channel Partners, Payers and many other Biopharmaceutical service providers. and / or facilitated. •Provides specialty channel design (exclusive, limited and open), specialty partner selection, pricing, contract and reimbursement primary research and analysis for new and existing biotechnology products across multiple therapeutic classes. •Preforms data analytical services to monitor and determine the effectiveness of their Specialty Product’s Market Access strategy.